- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/095 - OxytocinsVasopressinsRelated peptides
Patent holdings for IPC class A61K 38/095
Total number of patents in this class: 254
10-year publication summary
|
7
|
14
|
29
|
45
|
35
|
45
|
37
|
37
|
29
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ferring B.V. | 722 |
16 |
| Mallinckrodt Pharmaceuticals Ireland Ltd | 199 |
14 |
| ACADIA Pharmaceuticals Inc. | 194 |
8 |
| BIOVIE, Inc. | 36 |
8 |
| Amryt Pharmaceuticals, Inc. | 73 |
6 |
| PH Health Limited | 141 |
6 |
| Levo Therapeutics, Inc. | 13 |
5 |
| Maskbegone LLC | 5 |
5 |
| Arecor Limited | 106 |
4 |
| Monash University | 729 |
4 |
| Sunnybrook Research Institute | 264 |
4 |
| XOMA (US) LLC | 72 |
4 |
| Acerus Pharmaceuticals USA, LLC | 12 |
4 |
| Novartis AG | 10341 |
3 |
| The General Hospital Corporation | 4832 |
3 |
| The Trustees of Columbia University in the City of New York | 3636 |
3 |
| Centre hospitalier universitaire de Toulouse | 174 |
3 |
| MannKind Corporation | 528 |
3 |
| OptiNose AS | 23 |
3 |
| Tulex Pharmaceuticals Inc., DBA Tulex Pharmaceuticals Inc. | 22 |
3 |
| Other owners | 145 |